![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/ShahFeb2020Figure6.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/ShahFeb2020Figure10.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/ShahFeb2020Figure2.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![PDF] Tacrolimus Ointment Effectiveness and Safety of Tacrolimus in Vitiligo Children | Semantic Scholar PDF] Tacrolimus Ointment Effectiveness and Safety of Tacrolimus in Vitiligo Children | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/717256975271f11469f1e7ff0c272dcf33bba422/6-Figure9-1.png)
PDF] Tacrolimus Ointment Effectiveness and Safety of Tacrolimus in Vitiligo Children | Semantic Scholar
![Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate](https://d2ogjlfjkptkow.cloudfront.net/contentimage/21400.jpg)
Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate
![Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo](https://anndermatol.org/ArticleImage/0140AD/ad-27-104-g001-l.jpg)
Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo
![Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo - Xu - 2009 - International Journal of Dermatology - Wiley Online Library Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo - Xu - 2009 - International Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1ae7dfe5-6423-4a4f-b5a8-0302815e8802/ijd_3852_f1.gif)
Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo - Xu - 2009 - International Journal of Dermatology - Wiley Online Library
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/ShahFeb2020Figure1.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 - A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -](https://onlinelibrary.wiley.com/cms/asset/bc408870-ce96-428c-96cd-9056b31c9e33/ced12742-fig-0001-m.jpg)
A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -
![Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/63E9831B-1440-4FFD-8968-ACCB00343E2A/OriginalThumbnail/THUMBNAIL_shutterstock_1080517253.jpg)
Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
![Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2012/78/1/Images/ijdvl_2012_78_1_68_90949_f8.jpg)